MPG.eBooks - Description: Biologics versus immunomodulators for the treatment of ulcerative colitis

Cover Image

Read Now

Biologics versus immunomodulators for the treatment of ulcerative colitis a review of comparative clinical effectiveness and cost-effectiveness

This study aims to review the literature and understand the effectiveness and cost-effectiveness of biologics and immunomodulators among UC patients naïve to both types of drugs

Bibliographic Details
Main Authors:	Chao, Yi-Sheng, Loshak, Hannah (Author)
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH April 17, 2019, 2019
Edition:	Version 1.0
Series:	CADTH rapid response report: peer-reviewed summary with critical appraisal
Subjects:	Vaccines / Therapeutic Use Cost-benefit Analysis Colitis, Ulcerative / Therapy Biological Products / Therapeutic Use Treatment Outcome
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK549363
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	This study aims to review the literature and understand the effectiveness and cost-effectiveness of biologics and immunomodulators among UC patients naïve to both types of drugs
Physical Description:	1 PDF file (19 pages) illustration